180 related articles for article (PubMed ID: 33936513)
1. Predicting Tumor Cell Response to Synergistic Drug Combinations Using a Novel Simplified Deep Learning Model.
Zhang H; Feng J; Zeng A; Payne P; Li F
AMIA Annu Symp Proc; 2020; 2020():1364-1372. PubMed ID: 33936513
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
Zhang T; Zhang L; Payne PRO; Li F
Methods Mol Biol; 2021; 2194():223-238. PubMed ID: 32926369
[TBL] [Abstract][Full Text] [Related]
3. In silico drug combination discovery for personalized cancer therapy.
Jeon M; Kim S; Park S; Lee H; Kang J
BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
[TBL] [Abstract][Full Text] [Related]
4. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning.
Preuer K; Lewis RPI; Hochreiter S; Bender A; Bulusu KC; Klambauer G
Bioinformatics; 2018 May; 34(9):1538-1546. PubMed ID: 29253077
[TBL] [Abstract][Full Text] [Related]
5. TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
Liu Q; Xie L
PLoS Comput Biol; 2021 Feb; 17(2):e1008653. PubMed ID: 33577560
[TBL] [Abstract][Full Text] [Related]
6. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
[TBL] [Abstract][Full Text] [Related]
7. Investigating the relevance of major signaling pathways in cancer survival using a biologically meaningful deep learning model.
Feng J; Zhang H; Li F
BMC Bioinformatics; 2021 Feb; 22(1):47. PubMed ID: 33546587
[TBL] [Abstract][Full Text] [Related]
8. Predicting anticancer synergistic drug combinations based on multi-task learning.
Chen D; Wang X; Zhu H; Jiang Y; Li Y; Liu Q; Liu Q
BMC Bioinformatics; 2023 Nov; 24(1):448. PubMed ID: 38012551
[TBL] [Abstract][Full Text] [Related]
9. Predictive approaches for drug combination discovery in cancer.
Madani Tonekaboni SA; Soltan Ghoraie L; Manem VSK; Haibe-Kains B
Brief Bioinform; 2018 Mar; 19(2):263-276. PubMed ID: 27881431
[TBL] [Abstract][Full Text] [Related]
10. Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor.
Gan Y; Huang X; Guo W; Yan C; Zou G
Bioinformatics; 2023 Oct; 39(10):. PubMed ID: 37812255
[TBL] [Abstract][Full Text] [Related]
11. Predict effective drug combination by deep belief network and ontology fingerprints.
Chen G; Tsoi A; Xu H; Zheng WJ
J Biomed Inform; 2018 Sep; 85():149-154. PubMed ID: 30081101
[TBL] [Abstract][Full Text] [Related]
12. In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data.
Celebi R; Bear Don't Walk O; Movva R; Alpsoy S; Dumontier M
Sci Rep; 2019 Jun; 9(1):8949. PubMed ID: 31222109
[TBL] [Abstract][Full Text] [Related]
13. Drug synergy model for malignant diseases using deep learning.
Rani P; Dutta K; Kumar V
J Bioinform Comput Biol; 2023 Jun; 21(3):2350014. PubMed ID: 37350313
[TBL] [Abstract][Full Text] [Related]
14. SYNDEEP: a deep learning approach for the prediction of cancer drugs synergy.
Torkamannia A; Omidi Y; Ferdousi R
Sci Rep; 2023 Apr; 13(1):6184. PubMed ID: 37061563
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Approaches for Anti-cancer Drug Discovery.
Li K; Du Y; Li L; Wei DQ
Curr Drug Targets; 2020; 21(1):3-17. PubMed ID: 31549592
[TBL] [Abstract][Full Text] [Related]
16. DrugComboRanker: drug combination discovery based on target network analysis.
Huang L; Li F; Sheng J; Xia X; Ma J; Zhan M; Wong ST
Bioinformatics; 2014 Jun; 30(12):i228-36. PubMed ID: 24931988
[TBL] [Abstract][Full Text] [Related]
17. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.
Huang L; Brunell D; Stephan C; Mancuso J; Yu X; He B; Thompson TC; Zinner R; Kim J; Davies P; Wong STC
Bioinformatics; 2019 Oct; 35(19):3709-3717. PubMed ID: 30768150
[TBL] [Abstract][Full Text] [Related]
18. Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies.
Xu J; Regan-Fendt K; Deng S; Carson WE; Payne PRO; Li F
Pac Symp Biocomput; 2018; 23():92-103. PubMed ID: 29218872
[TBL] [Abstract][Full Text] [Related]
19. Current Advances and Limitations of Deep Learning in Anticancer Drug Sensitivity Prediction.
Tan X; Yu Y; Duan K; Zhang J; Sun P; Sun H
Curr Top Med Chem; 2020; 20(21):1858-1867. PubMed ID: 32648840
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to predicting the synergy of anti-cancer drug combinations using document-based feature extraction.
Shim Y; Lee M; Kim PJ; Kim HG
BMC Bioinformatics; 2022 May; 23(1):163. PubMed ID: 35513784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
